
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study”, Thromb Haemost, vol. 112, pp. 276-86, 2014.
, “An algorithm to derive a numerical daily dose from unstructured text dosage instructions”, Pharmacoepidemiol Drug Saf, vol. 15, pp. 161-6, 2006.
, “Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study”, Bmj, vol. 330, p. 389, 2005.
, “Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer”, Thromb Haemost, vol. 112, pp. 255-63, 2014.
, “Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study”, Thromb Haemost, vol. 117, pp. 57-65, 2017.
, “The freetext matching algorithm: a computer program to extract diagnoses and causes of death from unstructured text in electronic health records”, BMC Med Inform Decis Mak, vol. 12, p. 88, 2012.
, “Incidence of Lyme disease in the UK: a population-based cohort study”, BMJ Open, vol. 9, p. e025916, 2019.
, “Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England”, Ear Hear, vol. 36, pp. e69-75, 2015.
, “Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study”, Thromb Haemost, 2019.
, “Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013”, Heart, vol. 101, pp. 1748-54, 2015.
, “Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
, “Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients”, Br J Haematol, 2020.
, “Preferential prescribing of tibolone and combined estrogen plus progestogen therapy in postmenopausal women”, Menopause, vol. 14, pp. 518-27, 2007.
, “Prevalence of acute repetitive seizures (ARS) in the United Kingdom”, Epilepsy Res, vol. 87, pp. 137-43, 2009.
, “Reliability of coded data to identify earliest indications of cognitive decline, cognitive evaluation and Alzheimer's disease diagnosis: a pilot study in England”, BMJ Open, vol. 8, p. e019684, 2018.
, “Residual Risk of Stroke and Death in Anticoagulant-Treated Patients With Atrial Fibrillation”, JAMA Cardiol, vol. 1, pp. 366-8, 2016.
, “Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study”, J Thromb Haemost, vol. 14, pp. 1374-83, 2016.
, “A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
, “Testosterone treatment and risk of venous thromboembolism: population based case-control study”, Bmj, vol. 355, p. i5968, 2016.
, “Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study”, Thromb Haemost, vol. 115, pp. 31-9, 2016.
, “Thirteen-year trend in the persistence with vitamin K antagonists for venous thromboembolism in the UK: a cohort study”, Curr Med Res Opin, vol. 34, pp. 1985-1990, 2018.
, “Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study”, BMJ Open, vol. 3, 2013.
, “Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study”, Bmj, vol. 340, p. c249, 2010.
, “Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer”, Thromb Haemost, vol. 120, pp. 847-856, 2020.
,